Advisers could land $100 million payday from Actelion sale
LONDON, Jan 26 (Reuters) - Advisers could pocket up to $100 million in fees from Johnson & Johnson's $30 billion acquisition of Swiss biotech firm Actelion, the largest takeover of a European... [Source]
Publication Date:Origin: reuters.com
Category: mergersNews
Topics: Actelion, could, Advisers, European, largest takeover, biotech, Swiss, billion acquisition, Johnson's, Johnson, $100 million, pocket, (Reuters), LONDON, payday, million